IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 1 filers reported holding IMMUNE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,000 | -42.9% | 22,355 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -41.7% | 22,355 | 0.0% | 0.00% | – |
| Q4 2017 | $12,000 | -63.6% | 22,355 | 0.0% | 0.00% | – |
| Q3 2017 | $33,000 | -52.2% | 22,355 | 0.0% | 0.00% | – |
| Q2 2017 | $69,000 | +6.2% | 22,355 | -95.0% | 0.00% | – |
| Q1 2017 | $65,000 | – | 447,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 26,975 | $41,000 | 0.00% |
| VANGUARD GROUP INC | 226,437 | $342,000 | 0.00% |
| UBS Group AG | 6,562 | $10,000 | 0.00% |
| IFP Advisors, Inc | 1 | $0 | 0.00% |
| Advisor Group, Inc. | 3,750 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 22,355 | $33,000 | 0.00% |
| DEUTSCHE BANK AG\ | 4 | $0 | 0.00% |
| MORGAN STANLEY | 5 | $0 | 0.00% |
| BlackRock Inc. | 568 | $1,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 250 | $0 | 0.00% |